Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- Check2 days agoChange DetectedMajor change: new version v3.2.0 plus a government operating status notice; removal of v3.1.0 indicates the update to the latest release.SummaryDifference2%
- Check16 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' link removed.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to include new drug information and related topics, while some previous location and drug details have been removed. Notably, the facility name and specific location details have been added.SummaryDifference2%
- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.